Lineage Cell Therapeutics
LCTX
$1.05
Share price
-7.08%
Change (1 day)
-19.85%
Change (1 year)
Categories
Lineage Cell Therapeutics (LCTX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $38.99 M
According to Lineage Cell Therapeutics 's latest financial reports the company's total liabilities are $38.99 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Lineage Cell Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $38.99 M | -24.61% |
| 2022-12-31 | $51.72 M | -38.16% |
| 2021-12-31 | $83.64 M | 552.37% |
| 2020-12-31 | $12.82 M | -9.9% |
| 2019-12-31 | $14.23 M | 51.17% |
| 2018-12-31 | $9.41 M | 4.86% |
| 2017-12-31 | $8.97 M | -25.58% |
| 2016-12-31 | $12.06 M | -33.76% |
| 2015-12-31 | $18.21 M | 49.56% |
| 2014-12-31 | $12.17 M | -21.27% |
| 2013-12-31 | $15.46 M | 183.59% |
| 2012-12-31 | $5.45 M | 24.77% |
| 2011-12-31 | $4.37 M | 13.63% |
| 2010-12-31 | $3.84 M | 61.23% |
| 2009-12-31 | $2.38 M | -55.67% |
| 2008-12-31 | $5.38 M | 67.07% |
| 2007-12-31 | $3.22 M | 28.05% |
| 2006-12-31 | $2.51 M | 16.72% |
| 2005-12-31 | $2.15 M | 83.15% |
| 2004-12-31 | $1.17 M | -66.4% |
| 2003-12-31 | $3.5 M | 31.3% |
| 2002-12-31 | $2.66 M | 30.72% |
| 2001-12-31 | $2.04 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -28.41% | 🇺🇸 USA |